Suppr超能文献

六分钟步行距离可预测特发性肺纤维化患者在等待名单上的生存情况。

Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis.

作者信息

Lederer David J, Arcasoy Selim M, Wilt Jessie S, D'Ovidio Frank, Sonett Joshua R, Kawut Steven M

机构信息

Department of Medicine, College of Physicians and Surgeons, Joseph L. Mailman School of Public Health, Columbia University, New York, New York 10032, USA.

出版信息

Am J Respir Crit Care Med. 2006 Sep 15;174(6):659-64. doi: 10.1164/rccm.200604-520OC. Epub 2006 Jun 15.

Abstract

RATIONALE

Functional studies may be useful to predict survival in idiopathic pulmonary fibrosis (IPF). Various cutoffs of 6-min-walk distance (6MWD) have been suggested to identify patients at a high risk of death.

OBJECTIVES

To examine the association between 6MWD and survival in patients with IPF listed for lung transplantation, and to identify sensitive and specific cutoffs for predicting death at 6 mo.

METHODS

We performed a retrospective cohort study of 454 patients classified as having IPF listed for lung transplantation with the United Network for Organ Sharing between June 30, 2004 and July 22, 2005.

MEASUREMENTS AND MAIN RESULTS

Lower 6MWD was associated with an increased mortality rate (p value for linear trend < 0.0001). Patients with a walk distance less than 207 m had a more than fourfold greater mortality rate than those with a walk distance of 207 m or more, despite adjustment for demographics, anthropomorphics, FVC % predicted, pulmonary hypertension, and medical comorbidities (adjusted rate ratio, 4.7; 95% confidence interval, 2.5-8.9; p < 0.0001). 6MWD was a significantly better predictor of 6-mo mortality than was FVC % predicted (c-statistic = 0.73 vs. 0.59, respectively; p = 0.02).

CONCLUSIONS

Lower 6MWD was strongly and independently associated with an increased mortality rate for wait-listed patients classified as having IPF. 6MWD was a better predictor of death at 6 mo than was FVC % predicted.

摘要

理论依据

功能研究可能有助于预测特发性肺纤维化(IPF)患者的生存率。已提出多种6分钟步行距离(6MWD)的临界值来识别死亡风险高的患者。

目的

研究6MWD与等待肺移植的IPF患者生存率之间的关联,并确定预测6个月时死亡的敏感且特异的临界值。

方法

我们对2004年6月30日至2005年7月22日期间被器官共享联合网络分类为等待肺移植的454例IPF患者进行了一项回顾性队列研究。

测量指标与主要结果

较低的6MWD与死亡率增加相关(线性趋势p值<0.0001)。步行距离小于207米的患者死亡率比步行距离为207米或更长的患者高出四倍多,尽管对人口统计学、人体测量学、预测的FVC%、肺动脉高压和合并症进行了调整(调整后的率比为4.7;95%置信区间为2.5-8.9;p<0.0001)。6MWD对6个月死亡率的预测明显优于预测的FVC%(c统计量分别为0.73和0.59;p=0.02)。

结论

较低的6MWD与被分类为IPF的等待名单上患者的死亡率增加密切且独立相关。6MWD对6个月时死亡的预测优于预测的FVC%。

相似文献

1
Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med. 2006 Sep 15;174(6):659-64. doi: 10.1164/rccm.200604-520OC. Epub 2006 Jun 15.
2
The utility of 6-minute walk distance in predicting waitlist mortality for lung transplant candidates.
J Heart Lung Transplant. 2017 Jul;36(7):780-786. doi: 10.1016/j.healun.2016.12.015. Epub 2016 Dec 30.
3
Outcomes for patients with sarcoidosis awaiting lung transplantation.
Chest. 2002 Jul;122(1):233-8. doi: 10.1378/chest.122.1.233.
4
Six-minute walk distance and survival time in patients with idiopathic pulmonary fibrosis in Brazil.
J Bras Pneumol. 2018 Jul-Aug;44(4):267-272. doi: 10.1590/S1806-37562018000000049.
5
Clinical implications of six-minute walk test in patients with idiopathic pulmonary fibrosis: a retrospective cohort study.
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241275329. doi: 10.1177/17534666241275329.
6
Baseline 6-min walk distance predicts survival in lung transplant candidates.
Am J Transplant. 2008 Jul;8(7):1498-505. doi: 10.1111/j.1600-6143.2008.02264.x.
8
Six-minute walk distance predicts mortality in liver transplant candidates.
Liver Transpl. 2010 Dec;16(12):1373-8. doi: 10.1002/lt.22167.
10
Predictive utility of the 6-minute walk distance on survival in patients awaiting lung transplantation.
J Heart Lung Transplant. 2008 Jul;27(7):729-34. doi: 10.1016/j.healun.2008.03.017. Epub 2008 May 19.

引用本文的文献

1
Shorter walk test durations to detect ambulatory oxygen desaturation in interstitial lung disease: an observational cohort study.
ERJ Open Res. 2025 Jun 2;11(3). doi: 10.1183/23120541.00891-2024. eCollection 2025 May.
2
Revised Precapillary Pulmonary Hypertension Criteria and Their Prognostic Value in IPF Transplant Waitlist Survival.
Pulm Circ. 2025 Feb 2;15(1):e70046. doi: 10.1002/pul2.70046. eCollection 2025 Jan.
8
Using the 6-min walk test to assess the clinical response to mepolizumab and conventional therapy in severe eosinophilic asthma.
ERJ Open Res. 2023 Oct 2;9(5). doi: 10.1183/23120541.00114-2023. eCollection 2023 Sep.

本文引用的文献

1
Update in diffuse parenchymal lung diseases 2005.
Am J Respir Crit Care Med. 2006 May 15;173(10):1066-71. doi: 10.1164/rccm.2601011.
2
The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis.
Respir Med. 2006 Oct;100(10):1734-41. doi: 10.1016/j.rmed.2006.02.004. Epub 2006 Mar 20.
3
High-dose acetylcysteine in idiopathic pulmonary fibrosis.
N Engl J Med. 2005 Nov 24;353(21):2229-42. doi: 10.1056/NEJMoa042976.
5
High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis.
Am J Respir Crit Care Med. 2005 Aug 15;172(4):488-93. doi: 10.1164/rccm.200412-1756OC. Epub 2005 May 13.
7
Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med. 2005 May 1;171(9):1040-7. doi: 10.1164/rccm.200404-571OC. Epub 2005 Jan 21.
8
Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia.
Am J Respir Crit Care Med. 2005 Mar 15;171(6):639-44. doi: 10.1164/rccm.200403-331OC. Epub 2005 Jan 7.
9
Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia.
Am J Respir Crit Care Med. 2005 May 15;171(10):1150-7. doi: 10.1164/rccm.200405-578OC. Epub 2005 Jan 7.
10
The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis.
Eur Respir J. 2005 Jan;25(1):96-103. doi: 10.1183/09031936.04.00137203.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验